Study provides new look at why rare cancer often evades treatments
Por um escritor misterioso
Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
We've Got You Covered: Rebooting American Health Care: Einav, Liran, Finkelstein, Amy: 9780593421239: : Books
For a 6-year-old with cancer, a future staked on the promise of immunotherapy
Using genomics to guide personalized cancer treatment
Spatial transcriptomics—the next evolution of cancer drug discovery - 10x Genomics
Rewiring cell communication to treat melanoma
Answers to Unsolved Rare Disease Mysteries May Be on the Horizon
Scientists Diagnose Dinosaur With Malignant Bone Cancer - Cancer Health
Cancers, Free Full-Text
The cancer equation: Mathematically modelling the cure, The Independent
How to Harness the Immune System to Treat Cancer - - Life Extension
Outsmart Your Cancer: Alternative by Pierce, Tanya Harter
Study provides new look at why rare cancer often evades treatments
8 Lung Cancer Nursing Care Plans - Nurseslabs
New model helps identify mutations that drive cancer, MIT News
Breaking Through Cancer's Shield - The New York Times
de
por adulto (o preço varia de acordo com o tamanho do grupo)